Article
Structural and mechanistic study of a novel inhibitor of M. tuberculosis cytochrome bc1:aa3
2025-01-30
Abstract excerpt
<title>Abstract</title> <p>Drug-resistant tuberculosis (TB) continues to challenge treatment options, necessitating the exploration of new compounds of novel targets. The mycobacterial respiratory complex cytochrome bc1:aa3 has emerged as a promising target, exemplified by the success of first-in-class inhibitor Q203 in phase 2 clinical trial. However, to fully exploit the potential of this target and to identify...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6a705dfb-1661-566f-8030-841d0b8fdc2c
- DOI
- 10.21203/rs.3.rs-5630670/v1
